Light-Driven Plasma Membrane-to-Nucleus Cascade Targeting Achieves Concurrent Pyroptosis and STING Activation
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.6c14820 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Xingxing Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi712100, China. Hauptthemen laut MEDLINE: Pyroptosis, Photosensitizing Agents, Cell Membrane, Membrane Proteins. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Ministry of Education of the People's Republic of China.
Abstract (Originalsprache)
Sequential targeting of the plasma membrane and nucleus holds great promise for concurrent pyroptosis and STING-mediated antitumor immunity, but achieving such cascade localization with a single molecular entity remains challenging, as existing strategies rely on multi-component carriers or endogenous stimuli with limited spatiotemporal precision. Here, we report the first example of a light-driven, carrier-free, plasma membrane-to-nucleus cascade-targeting photosensitizer (PMNu-4-NI) that operates through a single small molecule. Designed with a hydrophobic, planar naphthalimide unit and a dicationic triphenylamine pyridinium core, PMNu-4-NI initially anchors in the plasma membrane. Upon light irradiation, localized ROS generation disrupts membrane integrity, triggering pyroptosis via the caspase-1/GSDMD pathway, while simultaneously releasing the molecule from the membrane. The liberated photosensitizer then translocates into the nucleus, where the naphthalimide moiety intercalates into DNA and activates the cGAS-STING pathway. This dual, time-resolved action couples membrane-initiated pyroptosis with nuclear-initiated STING activation, producing a robust immunogenic cell death response. In a murine 4T1 breast tumor model, PMNu-4-NI achieves potent antitumor efficacy with negligible systemic toxicity. Furthermore, in vivo immune profiling reveals enhanced CD8+ T cell infiltration, a significant abscopal effect, and effective suppression of lung metastasis, collectively confirming systemic antitumor immune activation. This work establishes a design paradigm for photodynamic immunotherapy and a generalizable platform for next-generation photosensitizers with programmable spatiotemporal dynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi712100, China.
- State Key Laboratory of Crystal Materials, Shandong University, Jinan250100, China.
- College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi712100, China.
ORCID-Profile: Kang-Nan Wang, Yanrong Zhang
Förderung
- Ministry of Education of the People's Republic of China
Zitieren
APA
Ma, X., Liu, L., Li, X. Q., Song, H., Zhao, Y., Aili, A., Wang, K. N., Mi, T., & Zhang, Y. (2026). Light-Driven Plasma Membrane-to-Nucleus Cascade Targeting Achieves Concurrent Pyroptosis and STING Activation. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c14820
Vancouver
Ma X, Liu L, Li XQ, Song H, Zhao Y, Aili A, et al. Light-Driven Plasma Membrane-to-Nucleus Cascade Targeting Achieves Concurrent Pyroptosis and STING Activation. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c14820
BibTeX
@article{Ma2026,
author = {Ma, Xingxing and Liu, Lingyu and Li, Xin-Qi and Song, Haitao and Zhao, Yile and Aili, Atikaimu and Wang, Kang-Nan and Mi, Tiejun and Zhang, Yanrong},
title = {Light-Driven Plasma Membrane-to-Nucleus Cascade Targeting Achieves Concurrent Pyroptosis and STING Activation},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c14820}
}
EUVIMED